JP Morgan India Pvt Ltd ("Manager to the Offer"), on behalf of Siemens AG ("Acquirer"), has issued this Corrigendum to the Public Announcement to the Shareholders of Bayer Diagnostics India Ltd ("Target Company"), which is in continuation of and should be read in conjunction with the Public Announcement ("PA") dated July 03, 2006, Corrigendum to the PA dated August 12, 2006 and Corrigendum to the PA dated March 24, 2007 and the Letter of Offer dated March 27, 2007, pursuant to and in compliance with the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 1997 and subsequent amendments thereto (the "Takeover Regulations"). The shareholders of the Target Company are required to note the following:
1. The Schedule of activates has been revised. The Revised Schedule of Activities should be read as follows:
------------------------------------------------------------------------------------------ Activity Original Schedule Revised Schedule ------------------------------------------------------------------------------------------ Specified Date July 07, 2006 July 07, 2006 Date of Opening of the Offer April 06, 2007 April 11, 2007 Date of Closing of the Offer April 25, 2007 April 30, 2007 ------------------------------------------------------------------------------------------